首页> 外文期刊>British Journal of Haematology >Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group.
【24h】

Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group.

机译:异基因造血干细胞移植(HSCT)后的嵌合体监测:代表英国国家白细胞免疫表型嵌合体工作组国家外部质量评估服务,使用基于短串联重复序列(STR)的技术的技术建议。

获取原文
获取原文并翻译 | 示例
           

摘要

Analysis of short tandem repeats (STR) is the predominant method for post-transplant monitoring of donor engraftment. It can enable early detection of disease relapse, level of engraftment and provide useful information on the graft-versus-host disease (GVHD)/graft-versus-tumour (GVT) effect, facilitating therapeutic intervention. Harmonization and standardization of techniques and result interpretation is essential to reduce the impact of laboratory variability on both clinical management and the results of multi-centre clinical trials. However, the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI) has highlighted significant issues inherent in STR testing that impact upon inter- and intra- laboratory variation. We present here consensus best practice guidelines and recommendations for STR chimerism testing, data interpretation and reporting that have been drawn up and agreed by a consortium of 11 UK and Eire clinical laboratories. This document uses data obtained from the UK NEQAS LI Post-Stem Cell Transplant (SCT) Chimerism Monitoring Programme.
机译:短串联重复序列(STR)的分析是供体植入后移植后监测的主要方法。它可以实现疾病复发的早期检测,移植水平,并提供有关移植物抗宿主病(GVHD)/移植物抗肿瘤(GVT)效果的有用信息,从而有助于治疗干预。技术和结果解释的统一和标准化对于减少实验室变异性对临床管理和多中心临床试验结果的影响至关重要。但是,英国国家白细胞免疫分型外部质量评估服务(UK NEQAS LI)强调了STR检测固有的重大问题,这些问题会影响实验室之间和实验室之间的差异。我们在此介绍由11个英国和Eire临床实验室组成的财团起草并同意的STR嵌合体测试,数据解释和报告的共识最佳实践指南和建议。本文档使用的数据来自英国NEQAS LI干细胞移植(SCT)嵌合体监测计划。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号